Literature DB >> 18787542

Acne vaccines: therapeutic option for the treatment of acne vulgaris?

Jenny Kim1.   

Abstract

Acne, one of the most common skin diseases, is caused by multiple factors, including Propionibacterium acnes. Studies suggest that responses to P. acnes by host immunity play important roles in its pathogenesis. Identifying immune modulators that attenuate inflammatory responses against P. acnes and the inhibition of bacterial growth may lead to novel avenues of immunologic intervention.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18787542     DOI： 10.1038/jid.2008.221

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


  4 in total

1.  Analysis of the Surface, Secreted, and Intracellular Proteome of Propionibacterium acnes.

Authors:  Yang Yu; Jackson Champer; Jenny Kim
Journal:  EuPA Open Proteom       Date:  2015-06-16

2.  Passive immunoprotection targeting a secreted CAMP factor of Propionibacterium acnes as a novel immunotherapeutic for acne vulgaris.

Authors:  Pei-Feng Liu; Teruaki Nakatsuji; Wenhong Zhu; Richard L Gallo; Chun-Ming Huang
Journal:  Vaccine       Date:  2011-02-26       Impact factor: 3.641

3.  Different Propionibacterium acnes Phylotypes Induce Distinct Immune Responses and Express Unique Surface and Secreted Proteomes.

Authors:  Yang Yu; Jackson Champer; George W Agak; Stephanie Kao; Robert L Modlin; Jenny Kim
Journal:  J Invest Dermatol       Date:  2016-07-01       Impact factor: 8.551

4.  Generation and characterization of chicken egg yolk antibodies against propionibacterium acnes for the prevention of acne vulgaris.

Authors:  Karthika Selvan; R Sentila; A Michael
Journal:  Indian J Dermatol       Date:  2012-01       Impact factor: 1.494
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.